Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Triveni Bio

Triveni Bio

Series CUStriveni.bio
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$65.0Msum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Jun 17, 2026
    Series C · $65.0M (disclosed)
    Ascenta Capital (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Triveni Bio Raises $65 Million Series C Financing to Expand Scope of First-in-Class Bispecific TRIV-573 Clinical Studies and Drive Next-Stage Company Growth”
Investors on record
2 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jun 17, 2026
    Triveni Bio announced Series C of $65,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
3 observations
Every observation on this company